SCHEMBL2193235

SCHEMBL2193235

Cc1ccc2nc(-c3ccc(NC(=O)c4ccccc4N)cc3)sc2c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.73
TP53 P04637 6/20 0.73
SMN1; SMN2 Q16637 8/20 0.68
NPC1 O15118 10/20 0.60
RAB9A P51151 9/20 0.60
KDM4E B2RXH2 7/20 0.60
ALDH1A1 P00352 6/20 0.60
HPGD P15428 5/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
RXFP1 Q9HBX9 1/20 0.60
LMNA P02545 2/20 0.59
NFKB1 P19838 1/20 0.59
NFKB2 Q00653 1/20 0.59
RELA Q04206 1/20 0.59
CASP3 P42574 1/20 0.58
SENP8 Q96LD8 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6227082 0.89 MAPT (0.76) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL2252511 0.88 MAPT (0.74) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL2193632 0.88 SULT1A1 (0.65) MAPTTP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL2194467 0.87 MAPT (0.59) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL2191266 0.85 MAPT (0.71) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL1984153 0.84 MMP2 (0.74) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL12422004 0.84 MAPT (0.63) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL2193506 0.84 MAPT (0.68) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL1071608 0.83 MAPT (0.67) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL12980051 0.83 MAPT (0.67) MAPTTP53SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2338059-B1 Ligands for aggregated tau molecules WISTA LAB LTD (SG) 2015-04-08 EP disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
CN-102224423-B Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-10-22 CN disclosed
CN-102224423-A Ligands for aggregated tau molecules WISTA LAB LTD 2011-10-19 CN disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
WO-2010034982-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. (SG) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 MAPT 1/4885TP53 94/4885SMN1; SMN2 1022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.